Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects

The Latest in Amyloidosis Research With Heather Landau, MD, Memorial Sloan Kettering Cancer Center
Heather Landau, MD Memorial Sloan Kettering Cancer Center Interview Date: February 28, 2017
Many multiple myeloma patients can also have amyloidosis - or protein buildup in specific organs. Dr. Heather Landau of the Memorial Sloan Kettering cancer center explains the different kinds of amyloidosis, current treatments and exciting clinical trials for these patients. These trials include myeloma drugs such as Ninlaro, carfilzomib, daratumumab and other standard treatments, but also a new drug called NEOD001 that can reverse amyloidosis in certain organs. This is a very informative show for amyloidosis patients with or without multiple myeloma.
Thanks to our episode sponsor
Heather Landau, MD Memorial Sloan Kettering Cancer Center Interview Date: February 28, 2017
Many multiple myeloma patients can also have amyloidosis - or protein buildup in specific organs. Dr. Heather Landau of the Memorial Sloan Kettering cancer center explains the different kinds of amyloidosis, current treatments and exciting clinical trials for these patients. These trials include myeloma drugs such as Ninlaro, carfilzomib, daratumumab and other standard treatments, but also a new drug called NEOD001 that can reverse amyloidosis in certain organs. This is a very informative show for amyloidosis patients with or without multiple myeloma.
Thanks to our episode sponsor

Jennifer Ahlstrom
